financetom
Business
financetom
/
Business
/
Weight-loss drug developer BioAge raises $198 mln in US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Weight-loss drug developer BioAge raises $198 mln in US IPO
Sep 25, 2024 9:53 PM

Sept 25 (Reuters) - BioAge Labs has raised $198 million

after pricing its upsized U.S. initial public offering at the

midpoint of the range at $18 per share, the weight-loss drug

developer said on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved